[Testotoxicosis].
Fuse
Hideki
H
Department of Urology, Faculty of Medicine, National University Corporation, University of Toyama.
Akashi
Takuya
T
Watanabe
Akihiko
A
D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001224:Aspartic Acid / Q000235:genetics; D000242:Cyclic AMP; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D007985:Leydig Cells / Q000378:metabolism; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009154:Mutation; D011379:Prognosis; D011629:Puberty, Precocious / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D011974:Receptors, LH / Q000235:genetics; D013148:Spironolactone / Q000627:therapeutic use; D013738:Testolactone / Q000627:therapeutic use; D013739:Testosterone / Q000096:biosynthesis
D047072:Aromatase Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D011974:Receptors, LH; D013148:Spironolactone; D001224:Aspartic Acid; D013739:Testosterone; D013738:Testolactone; D000242:Cyclic AMP